Meningitis Vaccines Market, By Type, By Brand, By Serotype, By Sales Channel, By Geography

Description

Meningitis vaccines market is estimated to be valued at USD 3.72 Bn in 2024 and is expected to reach USD 5.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	3.72 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	6.60%	2031 Value Projection:	5.81 Bn

Figure. Meningitis Vaccines Market Share (%), By Region, 2024

Meningitis is a potentially fatal inflammation of the protective membranes covering the brain and spinal cord known as meninges. It can be caused by various pathogens such as bacteria, viruses, parasites, and fungi. The most common causes of meningitis are viral and bacterial infections. Bacterial infections including those caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b can rapidly lead to serious illness and even death if not treated promptly with appropriate antibiotics. While timely treatment with antibiotics can cure most cases of bacterial meningitis, the infection may still lead to long-term disability in 10-15% of cases such as hearing loss, neurodevelopmental delay, and epilepsy or limb amputations. To prevent the occurrence of invasive meningococcal disease caused by N. meningitidis, vaccination is recommended. Meningococcal conjugate vaccines have been created to provide both direct protection and herd immunity, effectively controlling the spread of the disease within communities.

Market Dynamics

Global meningitis vaccines market growth is primarily driven by increasing burden of invasive meningococcal disease and implementation of large-scale immunization programs worldwide. For instance, as per the data published by the World Health Organization (WHO) in 2021, meningitis causes approximately 250,000-500,000 cases annually resulting in over 30,000 deaths, making it a public health priority. Evolving epidemiology of common pathogenic serogroups causing outbreaks, recommendations for routine immunization by national regulatory bodies and availability of vaccine combinations are expected to create robust growth opportunities in the market during the forecast period. However, factors such as high costs associated with the manufacturing and development of novel vaccines, vaccine stockouts during outbreaks, and lack of awareness in low and middle-income countries can hamper the market growth. Development of affordable multivalent vaccines covering emerging serotypes and expansion of immunization programs in developing nations present lucrative opportunities for player engagement and further market expansion.

Key Features of the Study

This report provides in-depth analysis of the global meningitis vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Sanofi, GSK plc., Serum Institute of India Ltd., Merck & co., Inc., Walvax Biotechnology Co., Ltd., Icepta Pharmaceuticals Ltd., and Hualan Biological Engineering Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

Type Insights
- Bivalent
- Quadrivalent
- Others
Brand Insights
- MenQuadfi
- Menveo
- Trumenba
- Bexsero
- Others
Age Group Insights
- Infants
- Adults
Serotype Insights
- Serotype A
- Serotype B
- Serotype C
- Serotype W-135
- Others
Sales Channel Insights
- Private
- Public
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Sanofi
- GSK plc.
- Serum Institute of India Ltd.
- Merck & co., Inc.
- Walvax Biotechnology Co., Ltd.
- Icepta Pharmaceuticals Ltd.
- Hualan Biological Engineering Inc.

Product Code: CMI5042

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Meningitis Vaccines Market, By Type
- Meningitis Vaccines Market, By Brand
- Meningitis Vaccines Market, By Age Group
- Meningitis Vaccines Market, By Serotype
- Meningitis Vaccines Market, By Sales Channel
- Meningitis Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Meningitis Vaccines Market, By Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Bivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Quadrivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Meningitis Vaccines Market, By Brand, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
MenQuadfi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Menveo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Trumenba
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Bexsero
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Meningitis Vaccines Market, By Age Group, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Infants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Meningitis Vaccines Market, By Serotype, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Serotype A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Serotype W-135
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Meningitis Vaccines Market, By Sales Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Meningitis Vaccines Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa

10. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Serum Institute of India Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Walvax Biotechnology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Icepta Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hualan Biological Engineering Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us